Host defense against Bacillus anthracis and its subversion by anthrax toxins: a role for type-IIA secreted phospholipase A2

References

• Lehrer RI. Primate defensins. Nat Rev Microbiol 2004; 2: 727–38
   PubMed Web of Science ®Google Scholar
• Van den Bosch H. Intracellular phospholipases A. Biochim Biophys Acta 1980; 604: 191–246
   PubMed Web of Science ®Google Scholar
• Murakami M, Kudo I. Phospholipase A2. J. Biochem 2002; 131: 285–92
   Google Scholar
• Six DA, Dennis EA. The expanding superfamily of phospholipase A2 enzymes: classification and characterization. Biochim Biophys Acta 2000; 1488: 1–19
   PubMed Web of Science ®Google Scholar
• Touqui L, Alaoui-El-Azher M. Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr Mol Med 2001; 1: 739–54
   PubMedGoogle Scholar
• Touqui L, Arbibe L. A role for phospholipase A2 in ARDS pathogenesis. Trends Mol Med 1999; 6: 244–9
   Google Scholar
• Nakos G, Kitsiouli E, Hatzidaki E, Koulouras V, Touqui L, Lekka M. Phospholipase A2 and PAF-acetylhydrolase in patients with acute respiratory distress syndrome. Crit Care Med 2005; 33: 772–9
   PubMed Web of Science ®Google Scholar
• Lewis JF, Lobe A. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 147: 218–33
   PubMed Web of Science ®Google Scholar
• Valentin E, Lambeau G. Increasing molecular diversity of secreted phospholipases A2 and their receptors and binding proteins. Biochim Biophys Acta 2000; 1488: 59–70
   PubMed Web of Science ®Google Scholar
• Weinrauch Y, Elsbach P, Madsen LM, Foreman A, Weiss J. The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J Clin Invest 1996; 97: 250–7
   PubMedGoogle Scholar
• Mock M, Fouet A. Anthrax. Annu Rev Microbiol 2001; 55: 647–71
   PubMed Web of Science ®Google Scholar
• Lincoln RE, Hodges DR, Klein F, Mahlandt BG, Jones FR, Jr, Haines BW, et al. Role of the lymphatics in the pathogenesis of anthrax. J Infect Dis 1965; 115: 481–94
   Google Scholar
• Ross JM. The pathogenesis of anthrax following the administration of spores by the respiratory route. J Pathol Bacteriol 1957; 73: 485–94
   Google Scholar
• Turnbull PC. Anthrax vaccines: past, present and future. Vaccine 1991; 9: 533–9
   PubMed Web of Science ®Google Scholar
• Baldari CT, Tonello F, Paccani SR, Montecucco C. Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol 2006; 27: 434–40
   PubMed Web of Science ®Google Scholar
• Zwartouw HT, Smith H. Polyglutamic acid from B. anthracis grown in vivo: structure and aggressin activity. Biochem J 1956; 63: 437–54
   PubMedGoogle Scholar
• Koduri RS, Gronroos JO, Laine VJ, Le Calvez C, Lambeau G, Nevalainen TJ, et al. Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A2. J Biol Chem 2002; 277: 5849–57
   PubMed Web of Science ®Google Scholar
• Hunt CL, Nauseef WM, Weiss JP. Effect of D-alanylation of (lipo)teichoic acids of Staphylococcus aureus on host secretory phospholipase A2 action before and after phagocytosis by human neutrophils. J Immunol 2006; 176: 4987–94
   Google Scholar
• Laine VJ, Grass DS, Nevalainen TJ. Protection by group II phospholipase A2 against Staphylococcus aureus. J Immunol 1999; 62: 7402–8
   Google Scholar
• Piris-Gimenez A, Wu YZ, Delclaux C, Touqui L, Gossens P. High bactericidal efficiency of type-IIA phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin. J Immunol 2004; 173: 521–30
   PubMedGoogle Scholar
• Arbibe L, Koumanov K, Vial D, Rougeot C, Faure G, Havet N, et al. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J Clin Invest 1998; 102: 1152–60
   PubMed Web of Science ®Google Scholar
• Piris-Gimenez A, Paya M, Lambeau G, Chignard M, Mock M, Touqui L, et al. In vivo protective role of human group IIA phospholipase A2 against experimental anthrax. J Immunol 2005; 175: 6786–91
   PubMed Web of Science ®Google Scholar
• Kim C, Gajendran N, Mittrucker HW, Weiwad M, Song YH, Hurwitz R, et al. Alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc Natl Acad Sci U S A 2005; 102: 4830–5
   PubMed Web of Science ®Google Scholar
• Wang W, Mulakala C, Ward SC, Jung G, Luong H, Pham D, et al. Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J Biol Chem 2006; 281: 32755–64
   PubMed Web of Science ®Google Scholar
• Orth K, Xu Z, Mudgett MB, Bao ZO, Palmer LE, Bliska JE, et al. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease YB. Science 2000; 290: 1594–6
   PubMed Web of Science ®Google Scholar